Abstract
Background
Cancer patients at the end of life take numerous medications. However, it has not been assessed what proportion of patients take unnecessary medications and which patients are at risk for doing so.
Methods
Cross-sectional survey of medications utilized by terminally ill ambulatory cancer patients, with the aim of identifying medications considered unnecessary as per explicit criteria. The criteria took into account whether drugs could benefit patients with terminal cancer.
Results
Among 87 patients, 21 (24%, 95% confidence interval [CI] 15.6–34.5%) were taking at least one unnecessary medication, the most common being gastric protectors. In multivariable analyses, patients with Charlson Comobidity Index ≤ 1 (OR: 4.49, CI95% 1.32–15.26; p = 0.01) or whose medication list had not been reconciled by physicians (OR: 6.38, CI95% 1.21–33.40; p = 0.02) were more likely to use an unnecessary medication.
Conclusion
Patients with advanced cancer take many medications considered unnecessary. Medication reconciliation should be performed routinely for these patients.
Similar content being viewed by others
References
Halevy A, Brody BA (1999) Medical futility in end-of-life care. JAMA 282(14):1331–1332
Honegger HP (1991) Avoiding futility: assessment of cancer patients in intensive care units. Ann Oncol 2(8):530–531
von Gruenigen VE, Daly BJ (2005) Futility: clinical decisions at the end-of-life in women with ovarian cancer. Gynecol Oncol 97(2):638–644
Jecker NS, Pearlman RA (1992) Medical futility. Who decides? Arch Intern Med 152(6):1140–1144
Burt RA (2002) The medical futility debate: patient choice, physician obligation, and end-of-life care. J Palliat Med 5(2):249–254
Cantor MD, Braddock CH 3rd, Derse AR et al (2003) Do-not-resuscitate orders and medical futility. Arch Intern Med 163(22):2689–2694
Kasman DL (2004) When is medical treatment futile? A guide for students, residents, and physicians. J Gen Intern Med 19(10):1053–1056
Khatcheressian J, Harrington SB, Lyckholm LJ, Smith TJ (2008) 'Futile care': what to do when your patient insists on chemotherapy that likely won't help. Oncology (Williston Park) 22(8):881–888, discussion 893, 896, 898
Riechelmann RP, Krzyzanowska MK, Zimmermann C (2009) Futile medication use in terminally ill cancer patients. Support Care Cancer 17(6):745–748
Riechelmann RP, Krzyzanowska MK, O'Carroll A, Zimmermann C (2007) Symptom and medication profiles among cancer patients attending a palliative care clinic. Support Care Cancer 15(12):1407–1412
Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM (2007) Prescribing in palliative care as death approaches. J Am Geriatr Soc 55(4):590–595
Riechelmann RP, Zimmermann C, Chin SN et al (2008) Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage 35(5):535–543
Corcoran ME (1997) Polypharmacy in the older patient with cancer. Cancer Control 4(5):419–428
Riechelmann RP, Del Giglio A (2009) Drug interactions in oncology: how common are they? Ann Oncol 20:1907–1912
Glare P, Virik K, Jones M et al (2003) A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ 327(7408):195–198
Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383
Curtis EB, Walsh TD (1993) Prescribing practices of a palliative care service. J Pain Symptom Manage 8(5):312–316
Mercadante S, Fulfaro F, Casuccio A (2001) Pattern of drug use by advanced cancer patients followed at home. J Palliat Care 17(1):37–40
Nauck F, Ostgathe C, Klaschik E et al (2004) Drugs in palliative care: results from a representative survey in Germany. Palliat Med 18(2):100–107
Nicholson A, Andrew I, Etherington R, Gamlin R, Lovel T, Lloyd J. (2001) Futile and inappropriate prescribing: an assessment of the issue in a series of patients admitted to a palliative care unit. The International Journal of Pharmacy Practice (September issue):71
Kite S, Wilkinson S (2002) Beyond futility: to what extent is the concept of futility useful in clinical decision-making about CPR? Lancet Oncol 3(10):638–642
Vollrath AM, Sinclair C, Hallenbeck J (2005) Discontinuing cardiovascular medications at the end of life: lipid-lowering agents. J Palliat Med 8(4):876–881
Samano ES, Ribeiro LM, Campos AS et al (2005) Use of complementary and alternative medicine by Brazilian oncologists. Eur J Cancer Care (Engl) 14(2):143–148
Basu TK (1985) Drug–vitamin interaction. Int J Vitam Nutr Res Suppl 27:247–258
Conflict of interests
The authors state that there is no conflict of interest in this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fede, A., Miranda, M., Antonangelo, D. et al. Use of unnecessary medications by patients with advanced cancer: cross-sectional survey. Support Care Cancer 19, 1313–1318 (2011). https://doi.org/10.1007/s00520-010-0947-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-010-0947-1